Clinical Study On The Combined Effect Of Koladi Upanaha Sweda (Herbal Warm Medicated Paste Wrapped By A Cloth) And Adityapaka Guggulu (Herbal Tablet) In Janu Sandhigata Vata Vis-A-Vis Osteoarthritis Of Knee Joint

An Open Label Single Arm Study On The Combined Effect Of Koladi Upanaha Sweda And Adityapaka Guggulu In Janu Sandhigata Vata Vis-A-Vis Osteoarthritis Of Knee Joint - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/036093

Enrollment

Registered

2021-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Koladi Upanaha Sweda Adityapaka Guggulu: Koladi Upanaha Sweda will be done for 7 consecutive days Adityapaka Guggulu at the dose of 1 gm thrice a day ( in the morning, afternoon and at

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Janu Sandhigata Vata will be selected based on the history clinical features and X-ray findings Patients with the clinical features of Osteoarthritis of Knee joint will be selected Both fresh patients and those who have undergone treatment for Janu Sandhigata Vata will be selected for the study

Exclusion criteria

Exclusion criteria: Post-surgical and prosthetic knee joints will be excluded. Subjects with history of recent trauma and fracture will be excluded. Pregnant women and lactating mothers will be excluded Subjects suffering from any other systemic disorders which interfere with the course of intervention will be excluded

Design outcomes

Primary

Measure	Time frame
To evaluate the combined therapeutic efficacy of Koladi upanaha sweda and Adityapaka Guggulu in the management of Janu Sandhigata vata vis-a-vis to Osteoarthritis of Knee Joint.Timepoint: 21 Days	—

Secondary

Measure	Time frame
NILTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr MANJUNATHA ADIGA

Skamch And RC

adiga.manjunatha@gmail.com9035715798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026